
Moving towards a golden age of drug discovery
Rajesh Kumar, Senior Director of Structural Biology at Schrodinger,… Read More

Rajesh Kumar, Senior Director of Structural Biology at Schrodinger,… Read More

Saurabh Singal, Founder of Molecule AI, examines the impact that quantum computing can, and will have, on drug discovery and development. A quantum leap in pharma In 2019, Google announced that its quantum computer had achieved a groundbreaking milestone1 – solving a problem in 200 seconds that would take the… Read More

Researchers have created a mathematical model that can accurately predict Alzheimer’s disease progression in individual patients, paving the way for personalised treatment and faster development of therapies. According to the model, the disease onset and rate of progression varies on a case by case basis, meaning… Read More

Astellas Pharma and MIMETAS, which specialises in human disease modelling, have entered a strategic partnership to develop treatments for cancer. The companies will use MIMETAS’ tumour models to support the next generation of immuno-oncological therapies. “We are excited to make this next step in… Read More

Matthew Clark, CEO of X-Chem, looks at what the future could hold for DNA-encoded library (DEL) technology. In the 13 years since it was first described, DNA-encoded library (DEL) technology has become a firmly established approach to small molecule hit generation in drug discovery. Most major pharma companies operate DEL… Read More

Scientists from Queen’s University Belfast have developed a computer-aided data tool that will predict novel sites of binding for potential drugs that are more selective, leading to more effective drug targeting, increasing therapeutic efficacy and reducing side effects. The data tool or protocol will uncover a novel class of… Read More